人类乳突病毒检测市场规模、占有率、趋势、产业分析报告：依产品、应用、技术、最终用途、地区，2025-2034年市场预测

根据Polaris Market Research的最新研究，全球人类乳突病毒（HPV）检测市场规模预计到2034年将达到55.4792亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

人类乳突病毒（HPV）检测市场涵盖用于检测生物样本中HPV病毒的诊断检测产品的销售和分销。这些检测主要用于女性健康，在子宫颈癌筛检中发挥关键作用，因为持续感染某些高风险HPV基因型是导致子宫颈癌的主要原因。该市场涵盖各种检测方式，例如识别HPV DNA或RNA的分子检测、相关设备、耗材以及实验室和医疗保健提供者提供的检测服务。

随着人们日益意识到HPV与子宫颈癌之间的关联、国家子宫颈癌筛检计画的实施以及诊断技术的进步，人类乳突病毒检测市场经历了显着成长。主要的市场驱动力是HPV检测日益被采用作为主要筛检工具或与传统HPV和子宫颈抹片检查结合使用。此外，更灵敏、更特异的HPV检测方法的开发以及自我采集选项的推出，提高市场渗透率和可及性。在持续的研究、市场对早期癌症检测日益成长的需求以及政府积极推动预防性医疗保健的推动下，市场前景仍然光明。

人类乳突病毒检测市场报告重点

依应用划分，子宫颈癌筛检细分市场目前占据全球最大市场占有率。这是因为其在常规筛检计画中发挥重要作用，并且越来越重视癌前病变的早期发现。

依产品划分，耗材子细分市场占据最大市场占有率，因为试剂、检测试剂盒和其他一次性材料是HPV检测的重复使用材料，而HPV检测在世界各地被大量用于筛检和诊断。

依技术划分，PCR子细分市场占据最大市场占有率，因为基于PCR的检测方法在检测HPV DNA方面具有高灵敏度和特异性，使其成为全球子宫颈癌筛检的首选技术。

依最终用途划分，医院和诊所占据最大市场占有率，因为这些医疗机构是大部分定期接受子宫颈癌筛检和诊断的人群的主要护理点。

依地区划分，北美目前在人类乳突病毒检测市场中占据最大市场占有率。预计在预测期内，亚太地区的人类乳突病毒检测市场成长率最高。

活跃于人类乳突病毒检测市场的主要公司包括QIAGEN N.V.、F. Hoffmann-La Roche AG、Hologic, Inc.、Abbott Laboratories、Becton, Dickinson and Company（BD）、Thermo Fisher Scientific Inc.、Danaher Corporation（Cepheid）、bioMerieux S.A.、GenMark Diagnostics, Inc.（Roche收购）、Agilent Technologies, Inc.、Luminex Corporation（DiaSorin S.p.A.）。

目录

第1章 简介

第2章 执行摘要

第3章 研究方法

第4章 全球人类乳突病毒检测市场洞察

• 市场概况
• 人类乳突病毒检测市场动态
  • 驱动因素与机会
    • 提高认知度与筛检项目
    • 检测方法的技术进步
    • 不断上升的HPV感染率
  • 限制因素与挑战
    • 认知度和侦测率低
• PESTEL分析
• 人类人类乳突病毒检测市场趋势
• 价值链分析
• COVID-19 影响分析

第5章 全球人类乳突病毒检测市场（依应用）

• 主要调查结果
• 简介
• 子宫颈癌筛检
• 阴道癌筛检

第6章 全球人类乳突病毒检测市场（依产品）

• 主要调查结果
• 简介
• 设备
• 耗材
• 服务

第7章 全球人类乳突病毒检测市场（依技术）

• 主要调查结果
• 简介
• PCR
• 免疫诊断
• 其他技术

第8章 全球人类乳突病毒检测市场（依最终用途）

• 主要调查结果
• 简介
• 医院和诊所
• 实验室
• 其他

第9章 全球人类乳突病毒检测市场（依地区）

• 主要调查结果
• 简介
  • 2020-2034年人类乳突病毒检测市场评估（依地区）
• 北美
  • 北美：依应用，2020-2034
  • 北美：依产品，2020-2034
  • 北美：依技术，2020-2034
  • 北美：依最终用途，2020-2034
  • 美国
  • 加拿大
• 欧洲
  • 欧洲：依应用，2020-2034
  • 欧洲：依产品，2020-2034
  • 欧洲：依技术，2020-2034
  • 欧洲：依最终用途，2020-2034
  • 英国
  • 法国
  • 德国
  • 义大利
  • 西班牙
  • 荷兰
  • 俄罗斯
  • 欧洲其他地区
• 亚太地区
  • 亚太地区：依应用，2020-2034
  • 亚太地区：依产品，2020-2034
  • 亚太地区：依技术，2020-2034
  • 亚太地区：依最终用途，2020-2034
  • 中国
  • 印度
  • 马来西亚
  • 日本
  • 印尼
  • 韩国
  • 澳洲
  • 其他亚太地区
• 中东和非洲
  • 中东和非洲：依应用，2020-2034
  • 中东和非洲：依产品，2020-2034
  • 中东和非洲：依技术，2020-2034
  • 中东和非洲：依最终用途，2020-2034
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 以色列
  • 南非
  • 中东和非洲其他地区
• 拉丁美洲
  • 拉丁美洲：依应用，2020-2034
  • 拉丁美洲：依产品，2020-2034
  • 拉丁美洲：依技术，2020-2034
  • 拉丁美洲：依最终用途，2020-2034
  • 墨西哥
  • 巴西
  • 阿根廷
  • 拉丁美洲其他地区

第10章 竞争格局

• 扩张与收购分析
  • 扩张
  • 收购
• 伙伴关係/合作/协议/公开

第11章 公司简介

• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson and Company（BD）
• bioMerieux S.A.
• Danaher Corporation（Cepheid）
• F. Hoffmann-La Roche AG
• GenMark Diagnostics, Inc.（acquired by Roche）
• Hologic, Inc.
• Luminex Corporation（DiaSorin S.p.A.）
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.

The global human papillomavirus (HPV) testing market size is expected to reach USD 5,547.92 Million by 2034, according to a new study by Polaris Market Research. The report "Human Papillomavirus Testing Market Size, Share, Trends, Industry Analysis Report: By Product (Instruments, Consumables, Services), By Application, By Technology, By End-use, and Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The human papillomavirus (HPV) testing market encompasses the sale and distribution of diagnostic tests used to detect the presence of the HPV virus in biological samples. Primarily utilized in women's health, these tests play a critical role in screening for cervical cancer, as persistent infections with certain high-risk HPV genotypes are the primary cause of this disease. The market includes various testing methodologies, such as molecular tests that identify HPV DNA or RNA, as well as related instruments, consumables, and testing services offered by laboratories and healthcare providers.

The human papillomavirus testing market is experiencing significant growth, driven by increasing awareness of the link between HPV and cervical cancer, the implementation of national cervical cancer screening programs, and advancements in diagnostic technologies. A key market drive is the growing adoption of HPV testing as a primary screening tool or in conjunction with traditional HPV and Pap test. Furthermore, the development of more sensitive and specific HPV assays, along with the introduction of self-sampling options, is enhancing market penetration and accessibility. The market outlook remains positive, fueled by ongoing research, increasing market demand for early cancer detection, and supportive government initiatives promoting preventive healthcare.

Human Papillomavirus Testing Market Report Highlights:

By application, the cervical cancer screening subsegment currently holds the largest market share globally due to its established role in routine screening programs and the strong emphasis on early detection of precancerous lesions.

By product, the consumables subsegment accounts for the largest market share because of the recurring need for reagents, assay kits, and other disposable materials in the high volume of HPV testing procedures conducted worldwide for screening and diagnosis.

By technology, the PCR subsegment commands the largest market share owing to the high sensitivity and specificity of PCR-based assays in detecting HPV DNA, making it the preferred technology for cervical cancer screening on a global scale.

By end-use, the hospitals & clinics subsegment holds the largest market share as these healthcare settings serve as the primary points of care for a significant portion of the population undergoing routine cervical cancer screening and diagnostic processes.

By region, North America currently holds the largest market share in the human papillomavirus testing market. The Asia Pacific region is anticipated to exhibit the highest growth rate in the human papillomavirus testing market over the forecast period.

Some of the major players actively operating in the human papillomavirus testing market include QIAGEN N.V., F. Hoffmann-La Roche AG, Hologic, Inc., Abbott Laboratories, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Danaher Corporation (Cepheid), bioMerieux S.A., GenMark Diagnostics, Inc. (acquired by Roche), Agilent Technologies, Inc., and Luminex Corporation (DiaSorin S.p.A.).

Polaris Market Research has segmented the Human Papillomavirus Testing market report based on application, product, technology, end-use, and region:

By Application Outlook (Revenue - USD Million, 2020-2034)

Cervical Cancer Screening

Vaginal Cancer Screening

By Product Outlook (Revenue - USD Million, 2020-2034)

Instruments

Consumables

Services

By Technology Outlook (Revenue - USD Million, 2020-2034)

PCR

Immunodiagnostics

Other Technologies

By End-Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals & Clinics

Laboratories

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Human Papillomavirus Testing Market Insights

• 4.1. Human Papillomavirus Testing Market - Market Snapshot
• 4.2. Human Papillomavirus Testing Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Awareness and Screening Programs
    • 4.2.1.2. Technological Advancements in Testing Methods
    • 4.2.1.3. Increasing Prevalence of HPV Infections
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Low awareness and screening rates
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Human Papillomavirus Testing Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Human Papillomavirus Testing Market, by Application

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• 5.3. Cervical Cancer Screening
  • 5.3.1. Global Human Papillomavirus Testing Market, by Cervical Cancer Screening, by Region, 2020-2034 (USD Million)
• 5.4. Vaginal Cancer Screening
  • 5.4.1. Global Human Papillomavirus Testing Market, by Vaginal Cancer Screening, by Region, 2020-2034 (USD Million)

6. Global Human Papillomavirus Testing Market, by Product

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• 6.3. Instruments
  • 6.3.1. Global Human Papillomavirus Testing Market, by Instruments, by Region, 2020-2034 (USD Million)
• 6.4. Consumables
  • 6.4.1. Global Human Papillomavirus Testing Market, by Consumables, by Region, 2020-2034 (USD Million)
• 6.5. Services
  • 6.5.1. Global Human Papillomavirus Testing Market, by Services, by Region, 2020-2034 (USD Million)

7. Global Human Papillomavirus Testing Market, by Technology

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• 7.3. PCR
  • 7.3.1. Global Human Papillomavirus Testing Market, by PCR, by Region, 2020-2034 (USD Million)
• 7.4. Immunodiagnostics
  • 7.4.1. Global Human Papillomavirus Testing Market, by Immunodiagnostics, by Region, 2020-2034 (USD Million)
• 7.5. Other Technologies
  • 7.5.1. Global Human Papillomavirus Testing Market, by Other Technologies, by Region, 2020-2034 (USD Million)

8. Global Human Papillomavirus Testing Market, by End-Use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 8.3. Hospitals & Clinics
  • 8.3.1. Global Human Papillomavirus Testing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Million)
• 8.4. Laboratories
  • 8.4.1. Global Human Papillomavirus Testing Market, by Laboratories, by Region, 2020-2034 (USD Million)
• 8.5. Others
  • 8.5.1. Global Human Papillomavirus Testing Market, by Others, by Region, 2020-2034 (USD Million)

9. Global Human Papillomavirus Testing Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Human Papillomavirus Testing Market Assessment, By Geography, 2020-2034 (USD Million)
• 9.3. Human Papillomavirus Testing Market - North America
  • 9.3.1. North America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.3.2. North America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.3.3. North America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.3.4. North America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.3.5. Human Papillomavirus Testing Market - US
    • 9.3.5.1. US: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.3.5.2. US: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.3.5.3. US: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.3.5.4. US: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.3.6. Human Papillomavirus Testing Market - Canada
    • 9.3.6.1. Canada: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.3.6.2. Canada: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.3.6.3. Canada: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.3.6.4. Canada: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 9.4. Human Papillomavirus Testing Market - Europe
  • 9.4.1. Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.4.2. Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.4.3. Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.4.4. Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.5. Human Papillomavirus Testing Market - UK
    • 9.4.5.1. UK: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.5.2. UK: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.5.3. UK: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.5.4. UK: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.6. Human Papillomavirus Testing Market - France
    • 9.4.6.1. France: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.6.2. France: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.6.3. France: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.6.4. France: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.7. Human Papillomavirus Testing Market - Germany
    • 9.4.7.1. Germany: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.7.2. Germany: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.7.3. Germany: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.7.4. Germany: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.8. Human Papillomavirus Testing Market - Italy
    • 9.4.8.1. Italy: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.8.2. Italy: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.8.3. Italy: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.8.4. Italy: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.9. Human Papillomavirus Testing Market - Spain
    • 9.4.9.1. Spain: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.9.2. Spain: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.9.3. Spain: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.9.4. Spain: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.10. Human Papillomavirus Testing Market - Netherlands
    • 9.4.10.1. Netherlands: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.10.2. Netherlands: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.10.3. Netherlands: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.10.4. Netherlands: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.11. Human Papillomavirus Testing Market - Russia
    • 9.4.11.1. Russia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.11.2. Russia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.11.3. Russia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.11.4. Russia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.4.12. Human Papillomavirus Testing Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.4.12.2. Rest of Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.4.12.3. Rest of Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.4.12.4. Rest of Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 9.5. Human Papillomavirus Testing Market - Asia Pacific
  • 9.5.1. Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.5.2. Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.5.3. Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.5.4. Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.5. Human Papillomavirus Testing Market - China
    • 9.5.5.1. China: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.5.2. China: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.5.3. China: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.5.4. China: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.6. Human Papillomavirus Testing Market - India
    • 9.5.6.1. India: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.6.2. India: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.6.3. India: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.6.4. India: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.7. Human Papillomavirus Testing Market - Malaysia
    • 9.5.7.1. Malaysia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.7.2. Malaysia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.7.3. Malaysia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.7.4. Malaysia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.8. Human Papillomavirus Testing Market - Japan
    • 9.5.8.1. Japan: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.8.2. Japan: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.8.3. Japan: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.8.4. Japan: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.9. Human Papillomavirus Testing Market - Indonesia
    • 9.5.9.1. Indonesia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.9.2. Indonesia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.9.3. Indonesia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.9.4. Indonesia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.10. Human Papillomavirus Testing Market - South Korea
    • 9.5.10.1. South Korea: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.10.2. South Korea: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.10.3. South Korea: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.10.4. South Korea: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.11. Human Papillomavirus Testing Market - Australia
    • 9.5.11.1. Australia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.11.2. Australia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.11.3. Australia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.11.4. Australia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.5.12. Human Papillomavirus Testing Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.5.12.2. Rest of Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.5.12.3. Rest of Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.5.12.4. Rest of Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 9.6. Human Papillomavirus Testing Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.6.2. Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.6.3. Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.6.4. Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.5. Human Papillomavirus Testing Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.5.2. Saudi Arabia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.5.3. Saudi Arabia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.5.4. Saudi Arabia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.6. Human Papillomavirus Testing Market - UAE
    • 9.6.6.1. UAE: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.6.2. UAE: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.6.3. UAE: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.6.4. UAE: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.7. Human Papillomavirus Testing Market - Israel
    • 9.6.7.1. Israel: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.7.2. Israel: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.7.3. Israel: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.7.4. Israel: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.8. Human Papillomavirus Testing Market - South Africa
    • 9.6.8.1. South Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.8.2. South Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.8.3. South Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.8.4. South Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.6.9. Human Papillomavirus Testing Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.6.9.2. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.6.9.3. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.6.9.4. Rest of Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• 9.7. Human Papillomavirus Testing Market - Latin America
  • 9.7.1. Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
  • 9.7.2. Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
  • 9.7.3. Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
  • 9.7.4. Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.7.5. Human Papillomavirus Testing Market - Mexico
    • 9.7.5.1. Mexico: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.7.5.2. Mexico: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.7.5.3. Mexico: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.5.4. Mexico: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.7.6. Human Papillomavirus Testing Market - Brazil
    • 9.7.6.1. Brazil: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.7.6.2. Brazil: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.7.6.3. Brazil: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.6.4. Brazil: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.7.7. Human Papillomavirus Testing Market - Argentina
    • 9.7.7.1. Argentina: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.7.7.2. Argentina: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.7.7.3. Argentina: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.7.4. Argentina: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
  • 9.7.8. Human Papillomavirus Testing Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
    • 9.7.8.2. Rest of Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
    • 9.7.8.3. Rest of Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
    • 9.7.8.4. Rest of Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbott Laboratories
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Agilent Technologies, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Becton, Dickinson and Company (BD)
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. bioMerieux S.A.
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Danaher Corporation (Cepheid)
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. F. Hoffmann-La Roche AG
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. GenMark Diagnostics, Inc. (acquired by Roche)
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Hologic, Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Luminex Corporation (DiaSorin S.p.A.)
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. QIAGEN N.V.
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Thermo Fisher Scientific Inc.
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development

List of Tables:

• Table 1 Global Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 2 Global Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 3 Global Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 4 Global Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 5 North America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 6 North America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 7 North America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 8 North America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 9 U.S.: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 10 U.S.: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 11 U.S.: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 12 U.S.: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 13 Canada: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 14 Canada: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 15 Canada: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 16 Canada: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 17 Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 18 Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 19 Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 20 Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 21 UK: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 22 UK: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 23 UK: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 24 UK: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 25 France: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 26 France: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 27 France: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 28 France: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 29 Germany: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 30 Germany: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 31 Germany: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 32 Germany: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 33 Italy: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 34 Italy: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 35 Italy: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 36 Italy: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 37 Spain: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 38 Spain: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 39 Spain: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 40 Spain: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 41 Netherlands: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 42 Netherlands: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 43 Netherlands: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 44 Netherlands: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 45 Russia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 46 Russia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 47 Russia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 48 Russia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 49 Rest of Europe: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 50 Rest of Europe: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 51 Rest of Europe: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 52 Rest of Europe: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 53 Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 54 Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 55 Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 56 Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 57 China: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 58 China: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 59 China: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 60 China: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 61 India: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 62 India: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 63 India: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 64 India: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 65 Malaysia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 66 Malaysia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 67 Malaysia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 68 Malaysia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 69 Japan: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 70 Japan: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 71 Japan: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 72 Japan: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 73 Indonesia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 74 Indonesia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 75 Indonesia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 76 Indonesia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 77 South Korea: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 78 South Korea: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 79 South Korea: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 80 South Korea: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 81 Australia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 82 Australia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 83 Australia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 84 Australia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 85 Rest of Asia Pacific: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 86 Rest of Asia Pacific: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 87 Rest of Asia Pacific: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 88 Rest of Asia Pacific: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 89 Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 90 Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 91 Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 92 Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 93 Saudi Arabia: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 94 Saudi Arabia: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 95 Saudi Arabia: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 96 Saudi Arabia: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 97 UAE: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 98 UAE: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 99 UAE: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 100 UAE: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 101 Israel: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 102 Israel: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 103 Israel: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 104 Israel: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 105 South Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 106 South Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 107 South Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 108 South Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 109 Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 110 Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 111 Rest of Middle East & Africa: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 112 Rest of Middle East & Africa: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 113 Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 114 Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 115 Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 116 Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 117 Mexico: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 118 Mexico: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 119 Mexico: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 120 Mexico: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 121 Brazil: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 122 Brazil: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 123 Brazil: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 124 Brazil: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 125 Argentina: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 126 Argentina: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 127 Argentina: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 128 Argentina: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)
• Table 129 Rest of Latin America: Human Papillomavirus Testing Market, by Application, 2020-2034 (USD Million)
• Table 130 Rest of Latin America: Human Papillomavirus Testing Market, by Product, 2020-2034 (USD Million)
• Table 131 Rest of Latin America: Human Papillomavirus Testing Market, by Technology, 2020-2034 (USD Million)
• Table 132 Rest of Latin America: Human Papillomavirus Testing Market, by End-Use, 2020-2034 (USD Million)

List of Figures:

• Figure 1. Global Human Papillomavirus Testing Market, 2020-2034 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Application
• Figure 7. Global Human Papillomavirus Testing Market, by Application, 2024 & 2034 (USD Million)
• Figure 8. Market by Product
• Figure 9. Global Human Papillomavirus Testing Market, by Product, 2024 & 2034 (USD Million)
• Figure 10. Market by Technology
• Figure 11. Global Human Papillomavirus Testing Market, by Technology, 2024 & 2034 (USD Million)
• Figure 12. Market by End-Use
• Figure 13. Global Human Papillomavirus Testing Market, by End-Use, 2024 & 2034 (USD Million)